Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 13.86
-0.08 (-0.57%)
Sep 18, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 20.71 billion as of September 18, 2026. Its market cap has decreased by -12.88% in one year.
Market Cap
20.71B
Enterprise Value
17.37B
Revenue
8.15B
Ranking
n/a
PE Ratio
16.95
Stock Price
13.86
ChartMarket Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 20.71B, an increase of 467.60%. That is a compound annual growth rate of 8.26%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 20.71B | -8.03% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 23.02B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 21.83B |
| Walvax Biotechnology | 21.29B |
| Shanghai Haoyuan Chemexpress | 21.07B |
| Hybio Pharmaceutical | 20.76B |
| Livzon Pharmaceutical Group | 20.65B |
| Jilin Aodong Pharmaceutical Group | 20.59B |
| Guangdong Zhongsheng Pharmaceutical | 20.59B |